KR102391636B1 - Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome - Google Patents

Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome Download PDF

Info

Publication number
KR102391636B1
KR102391636B1 KR1020210170925A KR20210170925A KR102391636B1 KR 102391636 B1 KR102391636 B1 KR 102391636B1 KR 1020210170925 A KR1020210170925 A KR 1020210170925A KR 20210170925 A KR20210170925 A KR 20210170925A KR 102391636 B1 KR102391636 B1 KR 102391636B1
Authority
KR
South Korea
Prior art keywords
exosomes
golden
exosome
yakmomil
cosmetic composition
Prior art date
Application number
KR1020210170925A
Other languages
Korean (ko)
Inventor
윤은정
박시준
김정수
김현민
조진성
Original Assignee
주식회사 에이바이오머티리얼즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 에이바이오머티리얼즈 filed Critical 주식회사 에이바이오머티리얼즈
Priority to KR1020210170925A priority Critical patent/KR102391636B1/en
Application granted granted Critical
Publication of KR102391636B1 publication Critical patent/KR102391636B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84Products or compounds obtained by lyophilisation, freeze-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a cosmetic composition for improving skin and hair condition containing exosomes derived from Scutellaria baicalensis and Houttuynia cordata. Specifically, the present invention relates to a cosmetic composition for improving skin and hair condition which has excellent effects of antioxidant, anti-inflammation, anti-wrinkle, hair growth promotion, and hair loss prevention by containing Scutellaria baicalensis exosome and Houttuynia cordata exosome purified by using hot air drying pretreatment and an aqueous two-phase system as active ingredients.

Description

황금, 약모밀 유래 엑소좀을 유효성분으로 함유하는 피부 및 모발 상태개선용 화장료 조성물{Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome}Golden, cosmetic composition for improving skin and hair condition containing exosomes derived from medicinal wool as an active ingredient {Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome}

본 발명은 황금, 약모밀 유래 엑소좀을 유효성분으로 함유하는 피부 및 모발 상태개선용 화장료 조성물에 관한 것으로, 구체적으로는 열풍건조 전처리와 수성 2상 시스템을 이용하여 정제된 황금 엑소좀 및/또는 약모밀 엑소좀을 유효성분으로 함유하여 항산화, 항염, 주름 개선효과와 모발 성장 촉진, 탈모 방지 효과가 우수한 피부 및 모발 상태개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for improving the condition of skin and hair containing exosomes derived from gold and ryegrass as an active ingredient, and specifically, golden exosomes and/or yak-mo-mil purified using hot air drying pretreatment and an aqueous two-phase system. It relates to a cosmetic composition for improving skin and hair conditions that contains exosomes as an active ingredient and has antioxidant, anti-inflammatory, wrinkle-improving effects, hair growth promotion, and hair loss prevention effects.

화장품의 기능은 청결과 단순한 메이크업을 지나, 공해 물질, 스트레스, 자외선, 활성산소, 과산화물 등의 피부 노화 원인을 제거하거나 억제하는 것으로 확장되어 왔다. 최근 들어 안전한 천연물을 소재로 하여 피부 주름을 개선하고, 피부 자극 및 염증을 완화시켜 주는 화장료의 개발이 활발하게 이루어지고 있다. 또한 현대사회에서는 모발 손상이나 탈모에 시달리는 사람들이 늘어나고 있으며 탈모증을 치료하기 위해 가발, 모이식 수술과 같은 외곽적인 시술이나 약물 치료와 같이 탈모증을 치료하기 위해 다양한 시도가 이루어지고 있다. 탈모의 원인은 유전적 원인, 모발 세포 기능 저하, 남성호르몬의 과잉 분비, 피지의 과잉 분비 등이 있으며 주로 남성호르몬인 안드로겐(androgen)이 중요한 인자로 작용되고 있다. 안드로겐 중 테스토스테론(testosterone)은 모낭에 도달하면 5알파-환원효소에 의해 디하이드로테스토스테론 (dihydrotestosterone:DHT)로 전환이 되고 이 호르몬은 모낭을 위축시키고 모발을 서서히 가늘게 만드는 성질이 있어 탈모를 일으킨다.The function of cosmetics has been extended beyond cleanliness and simple makeup to remove or suppress the causes of skin aging such as pollutants, stress, ultraviolet rays, free radicals, and peroxides. In recent years, the development of cosmetics that improve skin wrinkles and relieve skin irritation and inflammation by using safe natural materials as a material is being actively conducted. In addition, in modern society, more and more people are suffering from hair damage or hair loss, and various attempts are being made to treat alopecia, such as external procedures such as wigs and transplantation surgery, or drug treatment to treat alopecia. The causes of hair loss include genetic causes, decreased hair cell function, excessive secretion of male hormones, and excessive secretion of sebum, and androgens, which are male hormones, are mainly acting as important factors. Among androgens, testosterone is converted to dihydrotestosterone (DHT) by 5-alpha-reductase when it reaches the hair follicle.

이러한 탈모증의 치료에는 미녹시딜(minoxidil), 피나스테라이드(finasteride)를 함유한 제제가 대표적이지만 성기능장애, 기형아 출산 가능성, 저혈압, 빈맥, 심혈 관계 합병증과 같은 부작용이 발생함에 따라 사용에 많은 제약이 있다. 따라서 부작용이 없는 천연 소재를 이용한 발모제 및 헤어 관련 제품에 대한 연구가 활발하게 진행되고 있다.For the treatment of such alopecia, formulations containing minoxidil and finasteride are representative, but there are many restrictions on their use due to side effects such as sexual dysfunction, the possibility of birth defects, hypotension, tachycardia, and cardiovascular complications. Therefore, research on hair growth agents and hair-related products using natural materials without side effects is being actively conducted.

본 발명에서 "엑소좀(Exosome)"이란 다양한 세포들로부터 분비되는 막 구조의 작은 소낭을 의미하며, 세포밖 소포체(Extracellular Vesicles, EVs)의 한 종류로 정의된다. 모든 세포들은 다른 세포들 또는 외부 환경과 정보 교환을 하며 이를 위해 세포밖 소포체를 분비한다. 엑소좀은 50~200 nm 정도의 크기를 가지며 단백질, 지질, 핵산 등 생리활성 물질을 포함한다. 엑소좀은 포유류, 박테리아, 식물 등 다양한 세포에 존재하며 기원하는 세포들의 상태를 반영하고 있어 진단 및 치료에 활용할 수 있다. 엑소좀은 이중인지질막 구조체로 세포내 침투가 용이하고, 면역 반응, 신호전달과 같은 다양한 생리적, 병리적 기능을 수행한다. In the present invention, "exosome" means a small vesicle with a membrane structure secreted from various cells, and is defined as a type of extracellular vesicles (EVs). All cells exchange information with other cells or the external environment and secrete extracellular vesicles for this purpose. Exosomes have a size of about 50 to 200 nm and contain physiologically active substances such as proteins, lipids, and nucleic acids. Exosomes exist in various cells, such as mammals, bacteria, and plants, and reflect the state of cells of origin, so they can be used for diagnosis and treatment. Exosomes are a double phospholipid membrane structure that facilitates intracellular penetration and performs various physiological and pathological functions such as immune response and signal transduction.

최근에 식물에서 유래한 엑소좀의 다양한 효능에 관한 연구가 이루어지고 있으며 이의 항산화, 항염 등의 피부 효능에 대해서도 연구가 시작되고 있다. 식물 유래 엑소좀은 식물 세포 자체가 분비하는 생리활성 및 신호전달물질이 들어있어 세포간의 이동과 흡수에 도움을 주는 천연 나노입자이며, 식물에서 정제한 엑소좀은 포유류 유래 엑소좀에 비해 독성이 없다고 알려져 있다. Recently, research on various efficacy of plant-derived exosomes has been conducted, and research on skin efficacy such as antioxidant and anti-inflammatory has also been started. Plant-derived exosomes are natural nanoparticles that help in cell-to-cell movement and absorption as they contain physiological activity and signal transmitters secreted by plant cells themselves. is known

이러한 엑소좀은 다양한 장점 및 활성으로 인해 의약품, 화장품, 식품 등의 분야에서 활용이 가능한 소재이나 인지질이중막으로 구성되어 있는 구조적인 특징으로 인해 분산력이 낮고 응집하려는 성질이 있다. 또한 고온에서 불안정하고, 화장품 제형을 제조하는 과정에서 쉽게 깨질 수 있으며, 이러한 성질은 제형 내 엑소좀의 안정성을 저하시키고 침전을 일으킬 수 있다. 따라서 지속적인 활성 유지를 위해 수용액 내의 엑소좀의 용해도 및 분산성을 높여 제형 내 안정성을 높일 필요가 있다.These exosomes are materials that can be used in the fields of medicines, cosmetics, food, etc. due to various advantages and activities, but have low dispersibility and aggregation properties due to their structural features composed of a phospholipid bilayer. In addition, it is unstable at high temperatures and can be easily broken in the process of manufacturing a cosmetic formulation, and this property may reduce the stability of exosomes in the formulation and cause precipitation. Therefore, it is necessary to increase the stability in the formulation by increasing the solubility and dispersibility of the exosomes in the aqueous solution to maintain continuous activity.

본 발명자들은 다양한 방법을 적용하여 우수한 피부 및 모발 상태개선 활성을 나타내는 식물 유래 엑소좀을 제조하고 이를 화장료로 이용하기 위해 노력하였으며, 그 결과 특정한 조건에서의 열풍건조 전처리와 수성 2상 시스템을 이용하여 정제된 황금 엑소좀 및/또는 약모밀 엑소좀이 우수한 피부 및 모발 상태개선 효과를 나타낸다는 것을 확인하여 본 발명을 완성하였다.The present inventors applied various methods to prepare plant-derived exosomes exhibiting excellent skin and hair condition improvement activity and tried to use them as cosmetics. The present invention was completed by confirming that purified golden exosomes and/or weak wheat exosomes exhibit excellent skin and hair condition improvement effects.

(0001) 대한민국 등록특허 제10-2125567호 (2020.06.16)(0001) Republic of Korea Patent No. 10-2125567 (2020.06.16) (0002) 대한민국 등록특허 제10-2265811호 (2021.06.16.)(0002) Republic of Korea Patent Registration No. 10-2265811 (2021.06.16.) (0003) 대한민국 공개특허 제10-2021-0018735호 (2021.02.18)(0003) Republic of Korea Patent Publication No. 10-2021-0018735 (2021.02.18)

본 발명은 황금 엑소좀, 약모밀 엑소좀 또는 그 혼합 엑소좀을 유효성분으로 함유하여 안정성이 우수하며 항산화, 항염, 주름개선 효과, 모발 성장 촉진 및 탈모 방지 효과가 우수한 피부 및 모발 상태개선용 화장료 조성물을 제공하는 것을 목적으로 한다.The present invention is a cosmetic composition for improving skin and hair conditions, which contains golden exosomes, weak wheat exosomes, or mixed exosomes as active ingredients, and has excellent antioxidant, anti-inflammatory, wrinkle-improving effects, hair growth promotion and hair loss prevention effects. is intended to provide

또한, 본 발명은 황금 엑소좀 또는 약모밀 엑소좀의 정제방법을 제공하는 것을 다른 목적으로 한다.In addition, it is another object of the present invention to provide a method for purifying a little golden exo or yakmomil exo.

상기 목적을 달성하기 위하여 본 발명에 따르면, 황금 엑소좀, 약모밀 엑소좀 또는 그 혼합 엑소좀을 유효성분으로 함유하는 화장료 조성물이 제공된다.According to the present invention in order to achieve the above object, there is provided a cosmetic composition containing golden exosomes, yakmomil exosomes or mixed exosomes thereof as an active ingredient.

상기 유효성분으로서의 황금 엑소좀과 약모밀 엑소좀은,Golden exosomes and yakmomil exosomes as the active ingredients are,

(A) 황금 또는 약모밀을 40~60℃, 20~24시간 열풍건조 처리하는 단계; (B) 열풍건조 처리한 황금 또는 약모밀을 30~40℃의 물에 침지하는 단계; (C) 침지시킨 황금 또는 약모밀을 착즙하는 단계; (D)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계; (E)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계; (F)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및 (G)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 방법에 의하여 정제된 것이다.(A) 40 ~ 60 ℃, 20 ~ 24 hours hot-air drying treatment of golden or yak buckwheat; (B) immersing the hot-air dried golden or weak wheat in water at 30 ~ 40 ℃; (C) squeezing the immersed gold or yakmomil; (D) centrifuging the juice at 1,000xg to 10,000xg to obtain a supernatant; (E) freeze-drying the supernatant in which exosomes are present; (F) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; And (G) is purified by a method comprising the step of obtaining a supernatant in which the exosomes are concentrated in the aqueous two-phase system.

더욱 바람직하게는 상기 (A) 단계에서의 열풍건조 처리는 50℃의 온도에서 24시간 동안 수행하는 것이다.More preferably, the hot air drying treatment in step (A) is performed at a temperature of 50° C. for 24 hours.

유효성분으로서의 상기 황금 엑소좀, 약모밀 엑소좀 또는 그 혼합 엑소좀은 조성물 전체중량에 대하여 0.0001 ~ 30.0%(w/w) 함유된다.As an active ingredient, the golden exosome, yakmomil exosome, or a mixed exosome thereof is contained in an amount of 0.0001 to 30.0% (w/w) based on the total weight of the composition.

상기 화장료 조성물은 항산화용, 항염용 또는 주름개선용임을 특징으로 한다. 또한 상기 화장료 조성물은 모발 성장 촉진용 또는 탈모 방지용임을 특징으로 한다.The cosmetic composition is characterized in that it is for antioxidant, anti-inflammatory or wrinkle improvement. In addition, the cosmetic composition is characterized in that it is for promoting hair growth or preventing hair loss.

상기 다른 목적을 달성하기 위하여 본 발명에 따르면, According to the present invention to achieve the above other object,

(A) 황금 또는 약모밀을 40~60℃, 20~24시간 열풍건조 처리하는 단계; (A) 40 ~ 60 ℃, 20 ~ 24 hours hot-air drying treatment of golden or yak buckwheat;

(B) 열풍건조 처리한 황금 또는 약모밀을 30~40℃의 물에 침지하는 단계; (B) immersing the hot-air dried golden or weak wheat in water at 30 ~ 40 ℃;

(C) 침지시킨 황금 또는 약모밀을 착즙하는 단계; (C) squeezing the immersed gold or yakmomil;

(D)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계; (D) centrifuging the juice at 1,000xg to 10,000xg to obtain a supernatant;

(E)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계; (E) freeze-drying the supernatant in which exosomes are present;

(F)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및 (F) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; and

(G)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 황금 또는 약모밀 엑소좀의 정제방법이 제공된다.(G) There is provided a method for purifying golden or weak wheat exosomes comprising the step of obtaining a lower layer in which the exosomes are concentrated in the aqueous two-phase system.

상기 (A) 단계에서의 열풍건조 처리는 50℃의 온도에서 24시간 동안 수행하는 것임을 특징으로 한다.The hot air drying treatment in step (A) is characterized in that it is performed for 24 hours at a temperature of 50 ℃.

열풍건조 전처리와 수성 2상 시스템을 이용하여 정제된 본 발명의 황금 엑소좀, 약모밀 엑소좀 또는 그 혼합 엑소좀은 안정성이 우수하며, 우수한 항산화 효과, 항염 효과, 주름개선 효능 및 모발 성장 촉진 효능과 탈모 방지 효능을 나타내므로 피부 및 모발 상태개선용 화장료로 유용하게 사용될 수 있다.The golden exosomes, weak wheat exosomes, or mixed exosomes of the present invention, purified using hot air drying pretreatment and an aqueous two-phase system, have excellent stability, excellent antioxidant effect, anti-inflammatory effect, anti-wrinkle effect, and hair growth promoting effect. Since it exhibits the effect of preventing hair loss, it can be usefully used as a cosmetic for improving skin and hair conditions.

도 1은 본 발명의 일 실시예에 따라 정제된 황금 유래 엑소좀의 TEM 이미지이다.
도 2는 본 발명의 일 실시예에 따라 정제된 약모밀 유래 엑소좀의 TEM 이미지이다.
도 3은 본 발명의 일 실시예에 따라 정제된 황금 유래 엑소좀 입자의 크기 분포와 입자수를 확인하기 위한 NTA 분석 결과를 나타낸 그래프이다.
도 4는 본 발명의 일 실시예에 따라 정제된 약모밀 유래 엑소좀 입자의 크기 분포와 입자수를 확인하기 위한 NTA 분석 결과를 나타낸 그래프이다.
도 5는 본 발명에 의해 정제된 황금, 약모밀 유래 엑소좀의 세포 독성을 MTT assay로 평가한 결과를 나타낸 그래프이다.
도 6은 본 발명에 의해 정제된 황금, 약모밀 유래 엑소좀의 항염 효능을 NO(Nitric oxide) 생성 억제율로 평가한 결과를 나타낸 그래프이다.
도 7은 본 발명에 의해 정제된 황금, 약모밀 유래 엑소좀의 주름 개선 효능을 콜라겐 생성능으로 평가한 결과를 나타낸 그래프이다.
도 8은 본 발명에 의해 정제된 황금, 약모밀 유래 엑소좀의 모발 성장 촉진 효과를 모유두세포 증식 효과로 평가한 결과를 나타낸 그래프이다.
도 9는 본 발명에 의해 정제된 황금, 약모밀 유래 엑소좀의 탈모 방지 효능을 5알파-환원효소 저해 활성시험으로 평가한 결과를 나타낸 그래프이다.
1 is a TEM image of a gold-derived exosome purified according to an embodiment of the present invention.
Figure 2 is a TEM image of a yakmomil-derived exosome purified according to an embodiment of the present invention.
Figure 3 is a graph showing the results of NTA analysis for confirming the size distribution and the number of particles of the gold-derived exosome particles purified according to an embodiment of the present invention.
Figure 4 is a graph showing the results of NTA analysis for confirming the size distribution and the number of particles of exosomes derived from yakmomil purified according to an embodiment of the present invention.
5 is a graph showing the results of evaluating the cytotoxicity of gold, yakmomil-derived exosomes purified by the present invention by MTT assay.
Figure 6 is a graph showing the results of evaluation of the anti-inflammatory efficacy of the exosomes derived from gold and yakmomil purified by the present invention by the inhibition rate of nitric oxide (NO) production.
7 is a graph showing the results of evaluating the anti-wrinkle efficacy of gold-derived exosomes purified by the present invention by the collagen production ability.
Figure 8 is a graph showing the results of evaluating the hair growth promoting effect of the exosomes derived from gold and yak woolen purified by the present invention as the dermal papilla cell proliferation effect.
9 is a graph showing the results of evaluation of the hair loss prevention efficacy of gold-derived exosomes purified by the present invention by a 5-alpha-reductase inhibitory activity test.

이하, 본 발명을 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.

식물 유래 엑소좀은 식물 세포 자체가 분비하는 생리활성 및 신호전달물질을 함유하고 있으며, 포유류 유래 엑소좀에 비해 독성이 없다고 알려져 있다. 이러한 장점으로 인해 의약품, 화장품, 식품 등의 분야에서 활용이 가능한 소재이나 인지질 이중막으로 구성되어 있는 구조적인 특징으로 인해 분산력이 낮고 응집하려는 성질이 있어, 제형 내에서 그 활성을 지속적으로 유지하기 어렵다는 문제점을 가진다. 본 발명은 황금, 약모밀로부터 엑소좀을 고순도로 분리 정제하여, 이를 피부 및 모발용 화장료로 이용하는 것을 기술적 특징으로 한다.Plant-derived exosomes contain physiological activity and signaling substances secreted by plant cells themselves, and are known to be non-toxic compared to mammalian-derived exosomes. Due to these advantages, it is a material that can be used in pharmaceuticals, cosmetics, food, etc., but has a low dispersibility and a tendency to agglomerate due to the structural feature composed of a phospholipid bilayer, so it is difficult to continuously maintain its activity in the formulation. have a problem The present invention has a technical feature of separating and purifying exosomes from gold and yak milt, and using them as cosmetics for skin and hair.

황금(Scutellaria baicalensis)은 꿀풀과에 속하는 여러해살이 초본식물로 그 뿌리가 약재로 쓰이는데 차가운 성질로 인해 몸의 열을 내리는 한약재에 많이 사용하고 있다. 황금에는 바이카레인(Baicalein), 바이카린(Baicalin), 워고닌(Wogonin), 워고노사이드(Wogonoside) 등의 성분이 함유되어 있으며 이 성분들은 간의 면역 조절, 간세포 보호활성, 암세포 증식 저해, 세포 사멸 유도, 위염 및 위궤양 억제 활성에 도움을 준다. 또한 습진과 아토피성 피부염 등 알레르기성 피부염에 효과적이며 한방에서 종기, 종양, 등창, 단독 등의 피부 질환 치료에 사용되어 왔다. 그 외에 외부의 피부염증 반응, 화상에도 사용하는 등 피부에 대한 효능 또한 우수하며 항염증 작용이 있어 염증을 동반하는 각종 질병에 효과적인 약재이다.Gold (Scutellaria baicalensis) is a herbaceous perennial plant belonging to the family Lamiaceae, and its roots are used medicinally. Gold contains ingredients such as baicalein, baicalin, wogonin, and wogonoside, and these ingredients regulate the immune system of the liver, hepatoprotective activity, inhibit cancer cell proliferation, and It helps in inducing apoptosis and inhibiting gastritis and gastric ulcer. It is also effective in allergic dermatitis such as eczema and atopic dermatitis, and has been used in oriental medicine to treat skin diseases such as boils, tumors, sores, and soles. In addition, it has excellent effects on the skin, such as used for external skin inflammatory reactions and burns, and is an effective drug for various diseases accompanied by inflammation due to its anti-inflammatory action.

약모밀(Houttuynia cordata)은 쌍떡잎식물이며 후추목의 삼백초과에 속하는 다년생풀로 메밀의 잎과 비슷하게 생겼다고 해서 약모밀이라고 불리며 잎이나 뿌리 등 전체적으로 다양한 정유 성분을 함유하고 있어 물고기의 비린내가 난다고 하여 어성초(魚腥草)라고도 불린다. 약모밀의 전초에는 0.0049%의 정유 성분이 함유되어 있다. 이 정유 중에는 데카노일 아세트알데히드(Decanoyl acetaldehyde), 미르센(Myrcene), 로우릭 알데히드(Lauric aldehyde), 캐프릭 알데히드 (Capric aldehyde) 등이 있다. 약모밀은 체내 유해한 각종 염증과 노폐물을 제거하는데 뛰어난 효과가 있으며 미세먼지로 인하여 체내에 쌓여 있는 여러 유해 물질과 중금속을 배출하는데 뛰어난 효과가 있다. 어성초에 다량 들어있는 쿠에르치트린 성분은 두피의 모세혈관을 확장시켜 두피 내 염증과 노폐물 제거에 도움을 주기 때문에 두피 건강에 효과적이며 탈모 증상을 완화하는데도 큰 도움이 된다. 또한 쿠에르치트린 성분은 항균 및 소염 작용에 뛰어나기 때문에 피부의 잡티나 여드름, 각종 피부 트러블을 개선하는데 좋은 효과가 있다. 그 외에 항암 작용, 혈액 순환, 이뇨 작용에도 도움을 주며 해독 작용 및 기관지 건강에 좋은 천연물로 알려져 있다.Houttuynia cordata is a dicotyledonous plant, and is a perennial plant belonging to the Pepperaceae family. It is called buckwheat because it looks similar to the leaves of buckwheat. It is also called 草). The outpost of Yakmomil contains 0.0049% essential oil. Among these essential oils are Decanoyl acetaldehyde, Myrcene, Lauric aldehyde, and Capric aldehyde. Yak buckwheat has an excellent effect in removing various harmful inflammations and wastes in the body, and it has an excellent effect in discharging various harmful substances and heavy metals accumulated in the body due to fine dust. Quercitrin, which is contained in large amounts in eoseongcho, expands the capillaries of the scalp and helps to remove inflammation and wastes in the scalp, so it is effective for scalp health and is a great help in alleviating hair loss symptoms. In addition, since Quercitrin has excellent antibacterial and anti-inflammatory properties, it is effective in improving skin blemishes, acne, and various skin troubles. In addition, it helps with anticancer, blood circulation, and diuretic action, and is known as a natural product that is good for detoxification and bronchial health.

본 발명의 황금, 약모밀 유래 엑소좀은 다음과 같은 방법으로 정제된다.Golden, yakmomil-derived exosomes of the present invention are purified by the following method.

(A) 황금 또는 약모밀을 40~60℃, 20~24시간 열풍건조 처리하는 단계; (A) 40 ~ 60 ℃, 20 ~ 24 hours hot-air drying treatment of golden or yak buckwheat;

(B) 열풍건조 처리한 황금 또는 약모밀을 30~40℃의 물에 침지하는 단계; (B) immersing the hot-air dried golden or weak wheat in water at 30 ~ 40 ℃;

(C) 침지시킨 황금 또는 약모밀을 착즙하는 단계; (C) squeezing the immersed gold or yakmomil;

(D)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계; (D) centrifuging the juice at 1,000xg to 10,000xg to obtain a supernatant;

(E)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계; (E) freeze-drying the supernatant in which exosomes are present;

(F)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및 (F) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; and

(G)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 방법에 의하여 정제된다.(G) Purified by a method comprising the step of obtaining a supernatant in which the exosomes are concentrated in the aqueous two-phase system.

본 발명에서는 황금, 약모밀 유래 엑소좀을 제조하기 위하여 먼저 열풍건조 전처리를 수행한다.In the present invention, in order to produce exosomes derived from gold and yakmomil, a hot air drying pretreatment is first performed.

식물의 경우 환경적인 요인에 의해 엑소좀의 분비량이 달라질 수 있다. 따라서 식물이 엑소좀을 분비하는 최적의 조건은 다를 수 있다. 황금, 약모밀은 건조 조건에 따라 엑소좀의 분비가 다르게 나타나는 것을 확인하였다.In the case of plants, the amount of exosome secretion may vary depending on environmental factors. Therefore, the optimal conditions for plants to secrete exosomes may be different. It was confirmed that the secretion of exosomes differed according to the drying conditions in gold and yakmomil.

본 발명의 바람직한 일 구체예에 따르면, 상기 (A) 단계에서 열풍건조 전처리는 황금 또는 약모밀을 열풍건조기를 이용하여 40~60℃에서 20~24시간 열풍건조 처리하는 것으로 이루어진다. 더욱 바람직하게는 황금 또는 약모밀을 50℃, 24시간 열풍건조 처리하는 것으로 이루어진다.According to a preferred embodiment of the present invention, the hot-air drying pre-treatment in step (A) consists of hot-air drying treatment of golden or weak wheat at 40-60° C. for 20-24 hours using a hot-air dryer. More preferably, it consists of hot-air drying at 50° C. for 24 hours of golden or weak wheat.

이어서, 열풍건조 전처리된 황금, 약모밀을 30~40℃의 물에 3~6시간 동안 침지시킨 후 착즙한다((B), (C) 단계).Then, the hot air drying pre-treated golden and yak buckwheat is immersed in water at 30-40° C. for 3 to 6 hours and then juiced (steps (B) and (C)).

상기 (C) 단계에서 착즙하는 공정에 사용되는 스크류는 교반 속도가 20~50 rpm인 것을 사용하는 것이 바람직하다. As for the screw used in the process of juicing in step (C), it is preferable to use a screw having a stirring speed of 20 to 50 rpm.

상기 (D) 단계에서 사용되는 원심분리법은 크기, 모양, 밀도, 점성, 로터 속도에 따른 원심력을 이용하여 용액의 입자를 분리해내는 방법을 의미한다. 순차적으로 rpm을 조절하여 큰 오염 물질 제거가 필요하며 수성 2상계를 형성하기 위한 최종 용액을 얻기 위해서는 10,000xg에서 수행하는 것이 더욱 바람직하다.The centrifugation method used in step (D) refers to a method of separating particles of a solution using centrifugal force according to size, shape, density, viscosity, and rotor speed. It is necessary to sequentially control the rpm to remove large contaminants, and it is more preferable to carry out at 10,000xg to obtain a final solution for forming an aqueous two-phase system.

상기 (E) 단계에서 사용되는 동결건조는 용기의 온도를 급격하게 낮추어 건조시키고자 하는 물질을 얼린 다음 용기 내부의 압력을 진공에 가깝게 하여 재료에 포함된 고체화된 용매를 바로 수증기로 승화시켜 건조하는 방법이다. -50 ~ -80℃에서 15~24시간동안 동결하고, 동결건조기에서 진공상태로 72~120시간동안 건조한다. 이때 진공상태는 통상 동결건조기의 압력 상태를 의미한다.The freeze-drying used in step (E) freezes the material to be dried by rapidly lowering the temperature of the container, and then sublimes the solidified solvent contained in the material to water vapor by bringing the pressure inside the container close to vacuum and drying it. way. Freeze at -50 ~ -80℃ for 15~24 hours and dry in a freeze dryer for 72~120 hours under vacuum. At this time, the vacuum state usually means the pressure state of the freeze dryer.

엑소좀을 효율적으로 분리 정제하기 위하여 본 발명에서는 상호간에 잘 용해되지 않은 2종류의 수용액으로 2층을 만들어 각층으로의 친화성 차이를 이용한 분리법의 하나인 수성 2상분배법(aqueous two phase partition method)을 사용하였다.In order to efficiently separate and purify the exosomes, in the present invention, two layers are made with two types of aqueous solutions that are not well dissolved with each other, and the aqueous two phase partition method, which is one of the separation methods using the difference in affinity to each layer (aqueous two phase partition method) ) was used.

수성 2상계를 형성하는 방법에는 일반적으로 PEG/염(염으로는 sulfate, phosphate, citrate 등)도 사용할 수 있으나, 본 발명의 목적을 달성하기 위해서는 PEG/Dextran을 사용하는 것이 바람직하다. Dextran은 박테리아 작용에 의해 얻은 천연 고분자로 화장품 제형에서 점증제, 결합제, 벌킹제로 사용한다. Generally, PEG/salt (such as sulfate, phosphate, citrate, etc.) may be used in the method of forming an aqueous two-phase system, but in order to achieve the object of the present invention, it is preferable to use PEG/Dextran. Dextran is a natural polymer obtained by the action of bacteria and is used as a thickener, binder, and bulking agent in cosmetic formulations.

상기 (F) 단계에서 수성 2상계의 형성에 있어서 PEG는 분자량이 10,000~35,000인 것을 1~15중량%, 바람직하게는 2~5중량% 사용하고 Dextran은 분자량이 300,000~650,000인 것을 1~8 중량%, 바람직하게는 1~3중량% 사용하는 것을 특징으로 한다. 상기 PEG와 Dextran이 3.3중량%: 1.7중량%의 농도비율로 사용되는 경우에 엑소좀의 수율이 가장 높고, 안정성이 가장 우수하므로 더욱 바람직하다.In the formation of the aqueous two-phase system in step (F), 1 to 15% by weight of PEG having a molecular weight of 10,000 to 35,000, preferably 2 to 5% by weight, is used, and Dextran having a molecular weight of 300,000 to 650,000 is used in 1 to 8 % by weight, preferably 1 to 3% by weight. When the PEG and Dextran are used in a concentration ratio of 3.3% by weight: 1.7% by weight, the yield of the exosomes is the highest and the stability is the best, so it is more preferable.

엑소좀의 순도를 높이기 위해, 상기 (G)단계에 이어서 동일한 농도의 수성 2상계 용액을 사용하여 수성 2상계를 형성하고 하층액을 수득하는 과정을 2~3회 수행하는 공정을 추가적으로 수행할 수 있다.In order to increase the purity of the exosomes, a process of performing the process of forming an aqueous two-phase system using an aqueous two-phase solution of the same concentration and obtaining a lower layer solution 2-3 times subsequent to step (G) can be additionally performed. there is.

이와 같은 방법에 의하여 제조된 황금 엑소좀, 약모밀 엑소좀 및 그 혼합 엑소좀은 일반 황금 용매추출물, 약모밀 추출물과 비교하여 우수한 항산화 효과(시험예 8), 항염 효과(시험예 9), 주름 개선 효과(시험예 10, 시험예 11), 모발 성장 촉진 효과(시험예 12), 탈모방지 효과(시험예 13, 시험예 14)를 나타내었다.The golden exosomes prepared by this method, the medicinal wheat exosomes, and their mixed exosomes have excellent antioxidant effects (Test Example 8), anti-inflammatory effects (Test Example 9), and wrinkle improvement effects compared to general golden solvent extracts and medicinal wheat extracts. (Test Example 10, Test Example 11), hair growth promoting effect (Test Example 12), and hair loss prevention effect (Test Example 13, Test Example 14) were shown.

그러므로 상기 황금, 약모밀 유래 엑소좀은 항산화용, 항염용, 주름개선용 화장료 조성물에 사용될 수 있으며, 또한 모발 성장 촉진용, 탈모방지용 화장료 조성물에도 사용될 수 있다. 이때 상기 유효성분으로서의 황금, 약모밀 유래 엑소좀은 화장료 조성물 전체 중량에 대하여 0.0001 내지 30.0%(w/w) 함유될 수 있다.Therefore, the exosomes derived from gold and yak milt can be used in a cosmetic composition for antioxidant, anti-inflammatory, and wrinkle improvement, and can also be used in a cosmetic composition for promoting hair growth and preventing hair loss. In this case, gold, yakmomil-derived exosomes as the active ingredient may be contained in an amount of 0.0001 to 30.0% (w/w) based on the total weight of the cosmetic composition.

상기 화장료 조성물은 통상적으로 제조되는 어떠한 제형으로도 가능하며 예를 들면, 스킨로션, 스킨토너, 팩, 영양크림, 수분 크림, 에센스, 바디크림, 바디로션, 바디오일, 클렌징폼, 클렌징로션, 비누, 패치, 파운데이션, 립스틱, 메이크업 베이스, 립스틱 등으로 제조될 수 있다.The cosmetic composition can be in any conventionally prepared formulation, for example, skin lotion, skin toner, pack, nourishing cream, moisture cream, essence, body cream, body lotion, body oil, cleansing foam, cleansing lotion, soap , patch, foundation, lipstick, makeup base, lipstick, and the like.

또한 상기 화장료 조성물은 예를 들면, 헤어 토닉, 헤어 로션, 헤어 오일, 헤어 샴푸, 헤어 린스, 헤어 컨디셔너, 헤어 트리트먼트, 헤어 크림, 헤어 팩, 헤어 스프레이, 헤어 에센스, 헤어 무스, 헤어 겔 등으로 제조될 수 있다.In addition, the cosmetic composition is, for example, hair tonic, hair lotion, hair oil, hair shampoo, hair conditioner, hair conditioner, hair treatment, hair cream, hair pack, hair spray, hair essence, hair mousse, hair gel, etc. can be manufactured.

[실시예] [Example]

이하, 본 발명을 하기의 실시예 및 시험예에 의거하여 좀 더 상세하게 설명한다. 단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것이 아니고, 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 치환 및 균등한 타 실시예로 변경할 수 있음은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 명백할 것이다.Hereinafter, the present invention will be described in more detail based on the following Examples and Test Examples. However, the following examples are only for illustrating the present invention, and the present invention is not limited by the following examples, and can be changed to other examples with substitutions and equivalents within the scope without departing from the technical spirit of the present invention. will be apparent to those of ordinary skill in the art to which the present invention pertains.

실시예 1: 황금 엑소좀의 제조Example 1: Preparation of golden exosomes

황금 열풍건조 처리Golden hot air drying treatment

황금 생물 200g을 열풍건조기를 이용하여 50℃의 온도에서 24hr 열풍건조 처리를 실행하였다.200 g of golden organisms were subjected to 24 hr hot air drying treatment at a temperature of 50 ° C. using a hot air dryer.

황금 침지golden dipping

열풍건조 처리한 황금을 약 30~40℃의 물에 6시간동안 침지시켰다.The hot air-dried gold was immersed in water at about 30-40 ℃ for 6 hours.

황금 착즙golden juice

침지시킨 황금을 일반 착즙기를 사용하여 30 rpm의 저속 스크류로 황금 착즙을 수행하였으며 수득한 황금 착즙액은 메쉬망에 걸러 부유물을 제거하였다. 회수한 황금 착즙액은 정제를 진행하기 전까지 -80℃에서 보관하였다.The immersed gold was subjected to golden extraction using a general juicer with a low speed screw of 30 rpm, and the obtained golden juice was filtered through a mesh net to remove floating matter. The recovered golden juice was stored at -80°C until purification.

엑소좀 정제를 위한 상층액 회수Supernatant recovery for exosome purification

황금 착즙액은 엑소좀 정제를 위해 큰 오염 물질 제거가 필요하기 때문에 10,000xg에서 10분동안 4℃에서 원심분리를 수행하였다. 원심분리를 수행 후 수성 2상계를 형성하기 위해 상층액을 회수하였다.The golden juice was centrifuged at 10,000xg for 10 minutes at 4°C because large contaminants were required for exosome purification. After centrifugation, the supernatant was recovered to form an aqueous two-phase system.

상층액 동결건조Freeze-drying the supernatant

엑소좀의 대량생산을 위해 상층액의 부피를 줄이는 목적으로 동결건조를 수행하였다. -80℃에서 20시간동안 동결하고, 동결건조기에서 진공상태로 100시간동안 건조하였다. 이때 진공상태는 통상 동결건조기의 압력 상태를 의미하며 동결 및 건조 시간은 용액의 부피에 따라 달라질 수 있다.For mass production of exosomes, freeze-drying was performed for the purpose of reducing the volume of the supernatant. It was frozen at -80°C for 20 hours, and dried for 100 hours in a vacuum in a freeze dryer. At this time, the vacuum state usually means the pressure state of the freeze dryer, and the freezing and drying time may vary depending on the volume of the solution.

수성 2상계 형성formation of an aqueous two-phase system

동결건조한 상층액에 정제수를 추가하고 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하였다. PEG(Sigma Aldrich에서 구매)는 분자량이 10,000~35,000인 것을 3.3 중량% 사용하고 Dextran(Sigma Aldrich에서 구매)은 분자량이 300,000~650,000인 것을 1.7 중량% 사용하여 수성 2상 시스템을 형성하였다.Purified water was added to the freeze-dried supernatant, and an aqueous two-phase system was formed using PEG (Polyethylene glycol)/Dextran. An aqueous two-phase system was formed using 3.3 wt% of PEG (purchased from Sigma Aldrich) having a molecular weight of 10,000 to 35,000 and 1.7 wt% of Dextran (purchased from Sigma Aldrich) having a molecular weight of 300,000 to 650,000.

황금 엑소좀의 회수Recovery of golden exosomes

상층액과 PEG/Dextran 용액을 혼합한 후 1,000xg에서 10분동안 4℃에서 원심분리를 수행하였다. 원심분리 후 상층액을 제거하여 엑소좀을 회수하였다.After mixing the supernatant and the PEG/Dextran solution, centrifugation was performed at 1,000xg for 10 minutes at 4°C. After centrifugation, the supernatant was removed to recover exosomes.

추가 세척 공정Additional cleaning process

순도를 높이기 위해 회수된 하층액에 동일한 농도의 상기 수성 2상계 용액을 넣어 추가 세척 공정을 수행하였다. 3회 반복 처리 후 최종 엑소좀이 농축된 하층액을 회수하였다.In order to increase the purity, the aqueous two-phase solution of the same concentration was added to the recovered lower layer, and an additional washing process was performed. After repeated treatment three times, the final exosome-concentrated sublayer was recovered.

실시예 2: 약모밀 엑소좀의 제조Example 2: Preparation of yakmomil exosomes

상기 실시예 1과 동일하게 하여 약모밀 유래 엑소좀을 정제하였다.In the same manner as in Example 1, yakmomil-derived exosomes were purified.

실시예 3: 황금, 약모밀 혼합 엑소좀의 제조Example 3: Preparation of golden, yakmomil mixed exosomes

상기 실시예 1, 2에서 제조한 황금 엑소좀과 약모밀 엑소좀을 동일 중량비율로 혼합하여 혼합 엑소좀을 제조하였다.Mixed exosomes were prepared by mixing the golden exosomes prepared in Examples 1 and 2 and the yakmomil exosomes in the same weight ratio.

실시예 4~13: 황금, 약모밀 엑소좀의 제조Examples 4-13: Preparation of exosomes from golden, yak-milk

식물의 경우 환경적인 요인에 의해 엑소좀의 분비량이 달라질 수 있다. 식물이 엑소좀을 분비하는 최적의 조건이 모두 다르기 때문에 건조 환경 스트레스에 의한 엑소좀의 수율 비교를 통해 최적의 건조 조건을 확립하기 위해 황금과 약모밀의 건조 조건을 달리하여 생물을 건조 후 엑소좀을 정제하였다. 열풍 건조 조건만을 달리하고 상기 실시예 1과 동일하게 엑소좀을 정제하였으며 건조 조건은 하기의 표 1에 나타내었다.In the case of plants, the amount of exosome secretion may vary depending on environmental factors. Since the optimal conditions for the secretion of exosomes from plants are all different, in order to establish the optimal drying conditions through comparison of the yield of exosomes caused by dry environmental stress, the exosomes were dried after drying the organisms by different drying conditions of gold and ryegrass. Purified. Exosomes were purified in the same manner as in Example 1 except that only the hot air drying conditions were changed, and the drying conditions are shown in Table 1 below.

원물raw material 건조 온도 (℃)Drying temperature (℃) 건조 시간(hr)Drying time (hr) 실시예 4Example 4 황금Gold 4040 66 실시예 5Example 5 황금Gold 4040 2424 실시예 6Example 6 황금Gold 5050 66 실시예 7Example 7 황금Gold 6060 66 실시예 8Example 8 황금Gold 6060 2424 실시예 9Example 9 약모밀weak wheat 4040 66 실시예 10Example 10 약모밀weak wheat 4040 2424 실시예 11Example 11 약모밀weak wheat 5050 66 실시예 12Example 12 약모밀weak wheat 6060 66 실시예 13Example 13 약모밀weak wheat 6060 2424

비교예 1: 황금 추출물 제조Comparative Example 1: Preparation of golden extract

황금 건조물 10g을 정제수 100g에 넣고 80℃에서 3시간동안 추출하였다. 추출 후 감압여과를 수행하여 황금 추출물을 얻은 후 회전증발농축기를 사용하여 증류하여 파우더 형태로 샘플을 수득하였다.10 g of dry gold was added to 100 g of purified water and extracted at 80° C. for 3 hours. After extraction, filtration was performed under reduced pressure to obtain a golden extract, and then the sample was obtained in powder form by distillation using a rotary evaporator.

비교예 2: 약모밀 추출물 제조Comparative Example 2: Preparation of Yakmomil extract

약모밀 건조물 10g을 정제수 100g에 넣고 80℃에서 3시간동안 추출하였다. 추출 후 감압여과를 수행하여 약모밀 추출물을 얻은 후 회전증발농축기를 사용하여 증류하여 파우더 형태로 샘플을 수득하였다.10 g of dried buckwheat wheat was added to 100 g of purified water and extracted at 80° C. for 3 hours. After extraction, filtration under reduced pressure was performed to obtain an extract of buckwheat flour, followed by distillation using a rotary evaporator to obtain a sample in powder form.

시험예 1: 황금 유래 엑소좀의 특성 분석: TEM 분석Test Example 1: Characterization of gold-derived exosomes: TEM analysis

정제한 황금 유래 엑소좀의 모양을 확인하기 위해 투과 전자 현미경(TEM)으로 분석하였다. 도 1은 상기 실시예 1에 따라서 정제된 황금 유래 엑소좀의 TEM 분석 이미지이다. 분석 결과, 구형의 인지질 이중층 구조로 된 약 153.9nm의 입자의 존재를 확인하였다.In order to confirm the shape of the purified gold-derived exosomes, it was analyzed by transmission electron microscopy (TEM). 1 is a TEM analysis image of a gold-derived exosome purified according to Example 1. As a result of the analysis, it was confirmed the presence of particles of about 153.9 nm in a spherical phospholipid bilayer structure.

시험예 2: 약모밀 유래 엑소좀의 특성 분석: TEM 분석Test Example 2: Characteristics analysis of exosomes derived from Yakmomil: TEM analysis

정제한 약모밀 유래 엑소좀의 모양을 확인하기 위해 투과 전자 현미경(TEM)으로 분석하였다. 도 2는 상기 실시예 2에 따라서 정제된 약모밀 유래 엑소좀의 TEM 분석 이미지이다. 분석 결과, 구형의 인지질 이중층 구조로 된 약 160.2nm의 입자의 존재를 확인하였다.Transmission electron microscopy (TEM) was used to confirm the shape of the purified yakmomil-derived exosomes. Figure 2 is a TEM analysis image of the exosome derived from yakmomil purified according to Example 2 above. As a result of the analysis, it was confirmed the presence of about 160.2 nm particles having a spherical phospholipid bilayer structure.

시험예 3: 황금 유래 엑소좀의 특성 분석: NTA 분석Test Example 3: Characterization of gold-derived exosomes: NTA analysis

정제한 황금 유래 엑소좀의 입자 크기 분포와 단위 부피당 입자 수를 확인하기 위해 나노입자추적분석(Nanoparticle Tracking Analysis, NTA)으로 분석하였다. Nanoparticle Tracking Analysis (NTA) was used to confirm the particle size distribution and the number of particles per unit volume of the purified gold-derived exosomes.

도 3은 상기 실시예 1에 따라서 정제된 황금 유래 엑소좀의 NTA 분석 결과를 나타낸 그래프이며 분석 결과, 입자들의 평균 크기 153.9nm와 1 mL의 단위 부피당 6.80 × 1010 개의 농도를 확인하였다. 3 is a graph showing the results of NTA analysis of gold-derived exosomes purified according to Example 1, and as a result of the analysis, the average size of particles of 153.9 nm and the concentration of 6.80 × 10 10 per unit volume of 1 mL were confirmed.

시험예 4: 약모밀 유래 엑소좀의 특성 분석: NTA 분석Test Example 4: Characterization of exosomes derived from Yakmomil: NTA analysis

정제한 약모밀 유래 엑소좀의 입자 크기 분포와 단위 부피당 입자 수를 확인하기 위해 나노입자추적분석(Nanoparticle Tracking Analysis, NTA)으로 분석하였다. Nanoparticle Tracking Analysis (NTA) was used to confirm the particle size distribution and the number of particles per unit volume of the purified yakmomil-derived exosomes.

도 4는 상기 실시예 2에 따라서 정제된 약모밀 유래 엑소좀의 NTA 분석 결과를 나타낸 그래프이며 분석 결과, 입자들의 평균 크기 160.2nm와 1 mL의 단위 부피당 5.74 × 1010 개의 농도를 확인하였다. 4 is a graph showing the results of NTA analysis of yakmomil-derived exosomes purified according to Example 2, and as a result of the analysis, it was confirmed that the particles had an average size of 160.2 nm and a concentration of 5.74 × 10 10 per unit volume of 1 mL.

시험예 5: 황금, 약모밀 유래 엑소좀의 수율 비교Test Example 5: Comparison of yields of exosomes derived from gold and yakmomil

열풍건조의 최적의 조건을 확인하기 위해 상기 실시예 1, 2 및 4~13에 따라 정제한 황금, 약모밀 유래 엑소좀의 수율을 비교하였다. 하기 표 2는 수율 비교를 나노입자추적분석(NTA) 결과로 나타낸 표이다.In order to confirm the optimal conditions for hot air drying, the yields of exosomes derived from gold and yak buckwheat purified according to Examples 1, 2, and 4-13 were compared. Table 2 below is a table showing the yield comparison as a result of nanoparticle tracking analysis (NTA).

번호number Particle Number
(Particles/ml)
Particle Number
(Particles/ml)
Particle Size
(nm)
Particle Size
(nm)
실시예 1Example 1 6.80 x 1010 6.80 x 10 10 153.9153.9 실시예 2Example 2 5.74 x 1010 5.74 x 10 10 160.2160.2 실시예 4Example 4 2.14 x 109 2.14 x 10 9 140.3140.3 실시예 5Example 5 3.77 x 109 3.77 x 10 9 151.9151.9 실시예 6Example 6 5.09 x 109 5.09 x 10 9 147.5147.5 실시예 7Example 7 3.11 x 109 3.11 x 10 9 150.6150.6 실시예 8Example 8 1.97 x 1010 1.97 x 10 10 155.7155.7 실시예 9Example 9 7.11 x 109 7.11 x 10 9 161.4161.4 실시예 10Example 10 1.08 x 1010 1.08 x 10 10 167.5167.5 실시예 11Example 11 6.19 x 109 6.19 x 10 9 166.1166.1 실시예 12Example 12 5.78 x 109 5.78 x 10 9 152.0152.0 실시예 13Example 13 1.16 x 1010 1.16 x 10 10 152.9152.9

상기 표 2에서 확인되는 바와 같이 온도 40~60℃, 24시간 열풍건조 전처리 조건(실시예 1, 2, 8, 10, 13)에서 높은 수율을 나타내었으며, 그 중에서도 열풍건조 온도 50℃, 열풍건조 시간 24hr 조건의 실시예 1, 2에서 엑소좀의 수율이 가장 높았다. 따라서 가장 최적의 열풍건조 조건은 온도 50℃, 시간 24hr임을 확인하였다.As can be seen in Table 2 above, a high yield was exhibited at a temperature of 40 to 60° C. and a 24-hour hot air drying pretreatment condition (Examples 1, 2, 8, 10, 13), and among them, a hot air drying temperature of 50° C. and hot air drying The yield of exosomes was the highest in Examples 1 and 2 of the 24 hr condition. Therefore, it was confirmed that the most optimal hot air drying conditions were a temperature of 50° C. and a time of 24 hr.

시험예 6: 온도별 안정성 분석Test Example 6: Stability analysis by temperature

본 발명 실시예 1, 2에 따라 정제한 황금, 약모밀 유래 엑소좀의 온도별 안정성을 확인하였다. 하기 표 3은 상기 실시예 1, 2에 따라서 정제된 황금, 약모밀 유래 엑소좀을 12주 간 4℃, 25℃, 45℃에서 보관 후 나노입자추적분석(NTA)을 통해 입자의 크기와 농도를 나타낸 표이다.The stability of the exosomes derived from gold and yakmomil purified according to Examples 1 and 2 of the present invention at each temperature was confirmed. Table 3 below shows the size and concentration of the particles through nanoparticle tracking analysis (NTA) after storing the exosomes derived from gold and yak buckwheat purified according to Examples 1 and 2 at 4°C, 25°C, and 45°C for 12 weeks. table shown.

황금 엑소좀
(4℃보관)
golden exosome
(Storage at 4℃)
황금 엑소좀
(25℃보관)
golden exosome
(Stored at 25℃)
황금 엑소좀
(45℃보관)
golden exosome
(Storage at 45℃)
Particle Number
(Particles/ml)
Particle Number
(Particles/ml)
Particle Size(nm)Particle Size(nm) Particle Number
(Particles/ml)
Particle Number
(Particles/ml)
Particle Size(nm)Particle Size(nm) Particle Number
(Particles/ml)
Particle Number
(Particles/ml)
Particle Size(nm)Particle Size(nm)
초기Early 6.80 x 1010 6.80 x 10 10 153.9153.9 6.80 x 1010 6.80 x 10 10 153.9153.9 6.80 x 1010 6.80 x 10 10 153.9153.9 2주차2nd week 6.67 x 1010 6.67 x 10 10 149.1149.1 6.59 x 1010 6.59 x 10 10 151.7151.7 6.71 x 1010 6.71 x 10 10 153.4153.4 4주차4 weeks 6.53 x 1010 6.53 x 10 10 151.6151.6 6.54 x 1010 6.54 x 10 10 152.6152.6 6.68 x 1010 6.68 x 10 10 152.9152.9 8주차Week 8 6.55 x 1010 6.55 x 10 10 152.7152.7 6.63 x 1010 6.63 x 10 10 148.9148.9 6.70 x 1010 6.70 x 10 10 155.4155.4 12주차Week 12 6.57 x 1010 6.57 x 10 10 155.7155.7 6.57 x 1010 6.57 x 10 10 151.8151.8 6.69 x 1010 6.69 x 10 10 155.1155.1 약모밀 엑소좀
(4℃보관)
Mildew wheat exosome
(Storage at 4℃)
약모밀 엑소좀
(25℃보관)
Mildew wheat exosome
(Stored at 25℃)
약모밀 엑소좀
(45℃보관)
Mildew wheat exosome
(Storage at 45℃)
Particle Number
(Particles/ml)
Particle Number
(Particles/ml)
Particle Size(nm)Particle Size(nm) Particle Number
(Particles/ml)
Particle Number
(Particles/ml)
Particle Size(nm)Particle Size(nm) Particle Number
(Particles/ml)
Particle Number
(Particles/ml)
Particle Size(nm)Particle Size(nm)
초기Early 5.74 x 1010 5.74 x 10 10 160.2160.2 5.74 x 1010 5.74 x 10 10 160.2160.2 5.74 x 1010 5.74 x 10 10 160.2160.2 2주차2nd week 5.74 x 1010 5.74 x 10 10 161.8161.8 5.71 x 1010 5.71 x 10 10 158.0158.0 5.69 x 1010 5.69 x 10 10 157.4157.4 4주차4 weeks 5.68 x 1010 5.68 x 10 10 159.4159.4 5.69 x 1010 5.69 x 10 10 157.1157.1 5.70 x 1010 5.70 x 10 10 155.7155.7 8주차Week 8 5.62 x 1010 5.62 x 10 10 159.1159.1 5.70 x 1010 5.70 x 10 10 159.7159.7 5.75 x 1010 5.75 x 10 10 156.7156.7 12주차Week 12 5.69 x 1010 5.69 x 10 10 158.6158.6 5.75 x 1010 5.75 x 10 10 158.4158.4 5.79 x 1010 5.79 x 10 10 159.0159.0

온도별 12주 안정성을 분석한 결과, 실시예에 해당하는 황금, 약모밀 유래 엑소좀의 크기 및 농도 변화가 4℃, 25℃, 45℃ 조건에서 모두 안정적임을 확인하였다. As a result of analyzing the stability for 12 weeks by temperature, it was confirmed that the size and concentration changes of the exosomes derived from gold and yakmomil corresponding to Examples were all stable at 4 ℃, 25 ℃, and 45 ℃ conditions.

시험예 7: 세포독성 평가Test Example 7: Cytotoxicity evaluation

황금 엑소좀(실시예 1), 약모밀 엑소좀(실시예 2) 및 그 혼합엑소좀(실시예 3)과 황금 추출물(비교예 1), 약모밀 추출물(비교예 2)의 세포독성을 확인하기 위해 MTT assay 평가를 진행하였다. 96well 플레이트에 사람의 섬유아세포 세포주(human dermal fibroblast, HDFa)를 1×105 cells/mL의 농도로 접종 후 37℃로 18시간동안 5% CO2 하에 배양하였다. To confirm the cytotoxicity of golden exosomes (Example 1), yakmomil exosomes (Example 2) and their mixed exosomes (Example 3) and golden extracts (Comparative Example 1), and yakmomil extracts (Comparative Example 2) MTT assay was evaluated. Human dermal fibroblast (HDFa) was inoculated into a 96-well plate at a concentration of 1×10 5 cells/mL and then cultured at 37° C. for 18 hours under 5% CO 2 .

배양 후, 배지를 제거하고 PBS buffer로 세척한 후 새로운 배지에 황금 엑소좀, 약모밀 엑소좀, 그 혼합 엑소좀 및 황금 추출물, 약모밀 추출물을 농도 별로 투여하고 다시 24시간 동안 배양하였다. 세포의 생존율을 측정하기 위해 MTT solution(5mg/mL)을 첨가한 후 4시간 동안 형성된 formazan을 Dimethyl sulfoxide(DMSO)로 용해하고 ELISA reader를 이용하여 570nm에서 흡광도를 측정하였다. After incubation, the medium was removed and washed with PBS buffer, and then golden exosomes, yakmomil exosomes, their mixed exosomes, golden extracts, and yakmomil extracts were administered to a new medium by concentration, and cultured again for 24 hours. To measure the cell viability, formazan formed for 4 hours after addition of MTT solution (5 mg/mL) was dissolved in dimethyl sulfoxide (DMSO) and absorbance was measured at 570 nm using an ELISA reader.

도 5는 상기 시료들의 세포독성을 MTT assay로 평가한 결과를 나타낸 그래프이다. 시험 결과, 황금 엑소좀, 약모밀 엑소좀, 황금과 약모밀 혼합 엑소좀 및 황금 추출물, 약모밀 추출물을 처리하였을 때 모든 농도에서 세포독성이 나타나지 않았다.5 is a graph showing the results of evaluating the cytotoxicity of the samples by MTT assay. As a result of the test, no cytotoxicity was observed at all concentrations when treated with golden exosome, yakmomil exosome, golden and yakmomil mixed exosome, golden extract, and yakmomil extract.

시험예 8: 항산화 효능 평가Test Example 8: Antioxidant efficacy evaluation

황금 유래 엑소좀, 약모밀 유래 엑소좀 및 그 혼합 엑소좀의 항산화 효능을 확인하기 위해 각각의 추출물과 비교하여 DPPH 라디칼 소거 활성 시험을 진행하였다. DPPH 라디칼 소거 활성은 DPPH 라디칼에 대한 시료의 환원력으로 측정하였다. DPPH(1,1-Diphenyl-2-picrylhydrazyl) 시약을 에탄올에 용해하여 0.4mM 용액을 제조하였으며, 96 well plate에 농도별로 준비된 시료(엑소좀, 추출물) 또는 양성 대조군인 BHT(Butylated hydroxyl toluene 또는 2,6-Di-tert-butyl-p-cresol)를 에탄올에 용해한 용액 100㎕와 0.4 mM DPPH 용액 100㎕을 넣고 혼합하였다. 이때 음성 대조군으로는 에탄올을 처리하였으며 혼합 후 37℃에서 30분간 반응시켰다. ELISA reader를 이용하여 517㎚에서 흡광도를 측정하였으며 아래 계산식을 이용하여 시료 또는 양성대조군인 BHT의 DPPH 라디칼 소거능(%)을 계산하였다. In order to confirm the antioxidant efficacy of gold-derived exosomes, yakmomil-derived exosomes, and their mixed exosomes, a DPPH radical scavenging activity test was conducted in comparison with each extract. The DPPH radical scavenging activity was measured by the reducing power of the sample to the DPPH radical. A 0.4 mM solution was prepared by dissolving DPPH (1,1-Diphenyl-2-picrylhydrazyl) reagent in ethanol, and samples (exosomes, extracts) prepared by concentration in a 96 well plate or BHT (Butylated hydroxyl toluene or 2 ,6-Di-tert-butyl-p-cresol) in ethanol was mixed with 100 μl of a solution and 0.4 mM DPPH solution 100 μl. At this time, ethanol was treated as a negative control, and after mixing, it was reacted at 37° C. for 30 minutes. Absorbance was measured at 517 nm using an ELISA reader, and the DPPH radical scavenging ability (%) of the sample or positive control, BHT, was calculated using the formula below.

DPPH 라디칼 소거능(%) = {1-(양성 대조군 또는 시료의 흡광도/ 대조군의 흡광도)} × 100DPPH radical scavenging ability (%) = {1- (absorbance of positive control or sample / absorbance of control)} × 100

표 4는 각 시료의 항산화 효과를 DPPH 라디칼 소거능으로 평가한 결과를 나타낸 표이다.Table 4 is a table showing the results of evaluating the antioxidant effect of each sample by DPPH radical scavenging ability.

Concentration (%)Concentration (%) DPPH 라디칼 소거 활성 (%)DPPH radical scavenging activity (%) 황금 엑소좀
(실시예 1)
golden exosome
(Example 1)
약모밀 엑소좀
(실시예 2)
Mildew wheat exosome
(Example 2)
황금+ 약모밀
혼합 엑소좀
(실시예 3)
gold + wheat
mixed exosomes
(Example 3)
황금추출물
(비교예 1)
golden extract
(Comparative Example 1)
약모밀추출물
(비교예 2)
Mildew extract
(Comparative Example 2)
StockStock 6.80 x 1010 Particles/mL6.80 x 10 10 Particles/mL 5.74 x 1010 Particles/mL5.74 x 10 10 Particles/mL 6.27 x 1010 Particles/mL6.27 x 10 10 Particles/mL 100mg/mL100mg/mL 100mg/mL100mg/mL 0.0010.001 8.078.07 6.876.87 11.1811.18 0.840.84 1.271.27 0.010.01 18.4418.44 16.0816.08 22.9622.96 4.814.81 4.514.51 0.10.1 52.5552.55 51.4051.40 54.1954.19 27.4927.49 25.8725.87 1One 78.4778.47 77.1877.18 82.5982.59 54.1754.17 52.7752.77 BHT(0.01%)BHT (0.01%) 71.4971.49

시험 결과, 황금 유래 엑소좀, 약모밀 유래 엑소좀과 황금 추출물, 약모밀 추출물을 처리하였을 때 농도 의존적으로 DPPH 라디칼 소거 활성이 증가하였으며 용매 추출물에 비해 황금, 약모밀 유래 엑소좀을 처리하였을 때 활성이 더 증가됨을 확인하였다. 또한 황금과 약모밀 혼합 엑소좀을 처리하였을 때 가장 높은 활성을 나타내는 것을 확인하였다.As a result of the test, DPPH radical scavenging activity was increased in a concentration-dependent manner when gold-derived exosomes, yak-milk-derived exosomes, golden extract, and yak-mo-mil extract were treated. was confirmed. In addition, it was confirmed that the highest activity was shown when the golden and yakmomil mixed exosomes were treated.

시험예 9: 항염 효능 평가(NF-κB 발현)Test Example 9: Anti-inflammatory efficacy evaluation (NF-κB expression)

염증 부위에서 발현되는 염증 매개인자, 즉, 싸이토카인(cytokine), 케모카인(chemokine), 활성산소 중간생성물, 싸이클로옥시게나아제-2(cycloxygenase-2, COX-2), 5-리폭시게나아제(5-lipoxygenase, 5-LOX), 매 트릭스 매탈로프로티나아제(matrix metalloproteinase, MMP) 등은 염증반응의 발생 및 유지에 중요한 역할을 하는데 이러한 염증 매개인자들의 발현은 전사인자인 NF-κB(nuclear factor κB), STAT3(signal transducer and activator of transcription 3), AP-1(activator protein1), HIF-1a(hypoxia-inducible factor 1a) 등에 의하여 조절되는 것으로 알려져 있다.Inflammatory mediators expressed at the site of inflammation, that is, cytokines, chemokines, reactive oxygen species intermediates, cyclooxygenase-2 (COX-2), 5-lipoxygenase (5- Lipoxygenase, 5-LOX) and matrix metalloproteinase (MMP) play an important role in the generation and maintenance of an inflammatory response, and the expression of these inflammatory mediators is a transcription factor, nuclear factor κB ), STAT3 (signal transducer and activator of transcription 3), AP-1 (activator protein 1), HIF-1a (hypoxia-inducible factor 1a), etc. are known to be regulated.

따라서 황금, 약모밀 유래 엑소좀의 항염 효능을 확인하기 위해 추출물과 비교하여 NF-κB 유전자 발현 시험을 진행하였다. 사람의 표피 각질 세포주(human keratinocyte, HEKa)를 접종 후 100 IU/mL penicillin, 100 μg/mL streptomycin을 첨가한 Dulbecco Modified Eagle Medium (DMEM) 배양 배지에서 37℃로 24시간동안 5% CO2 하에 배양하였다. 배양 후 배지를 버리고 세포 손상을 유도하기 위해 UVB 20 mJ/cm2를 조사한 후 황금 엑소좀, 약모밀 엑소좀, 그 혼합 엑소좀 및 황금 추출물, 약모밀 추출물을 처리하고 48시간 배양하였다. 그 후 배양된 세포들을 TransZol reagent를 이용하여 RNA를 추출한 뒤 RT-PCR (실시간 유전자 중합효소 연쇄반응)을 진행하였고 PCR에 의하여 생성된 산물은 1% agarose gel에서 전기영동하여 Gel Documentation system으로 확인하였다. 이때 음성 대조군으로는 PBS를 처리하였으며 양성 대조군으로는 Allantoin 0.01%를 처리하였다. Therefore, the NF-κB gene expression test was performed in comparison with the extract to confirm the anti-inflammatory efficacy of exosomes derived from gold and yakmomil. After inoculation of a human epidermal keratinocyte line (HEKa), cultured in Dulbecco Modified Eagle Medium (DMEM) culture medium supplemented with 100 IU/mL penicillin and 100 μg/mL streptomycin at 37°C for 24 hours under 5% CO 2 did After culturing, the medium was discarded and UVB 20 mJ/cm 2 was irradiated to induce cell damage, followed by treatment with golden exosomes, yakmomil exosomes, their mixed exosomes, golden extracts, and yakmomil extracts, and cultured for 48 hours. After that, RNA was extracted from the cultured cells using TransZol reagent, followed by RT-PCR (real-time gene polymerase chain reaction), and the PCR product was electrophoresed on 1% agarose gel and confirmed with the Gel Documentation system . At this time, PBS was treated as a negative control and 0.01% of Allantoin was treated as a positive control.

도 6은 상기 시료들의 항염 효능을 NF-κB 발현으로 평가한 결과를 나타낸 그래프이다. 시험 결과, 황금 유래 엑소좀과 약모밀 유래 엑소좀을 처리하였을 때 농도 의존적으로 NF-κB 발현이 감소하였으며 황금 추출물과 약모밀 추출물을 처리하였을 때보다 훨씬 더 높은 감소율을 확인하였다. 또한 황금과 약모밀 혼합 엑소좀을 처리하였을 때 더 높은 감소율을 확인하였다. 이 때 양성 대조군인 Allantoin 0.01%를 처리하였을 때는 50.66% 발현율을 보였다.6 is a graph showing the results of evaluating the anti-inflammatory efficacy of the samples by NF-κB expression. As a result of the test, NF-κB expression was decreased in a concentration-dependent manner when gold-derived exosomes and yak-momil-derived exosomes were treated, and a much higher reduction rate was confirmed than when gold extracts and yak-milk extracts were treated. In addition, a higher reduction rate was confirmed when the golden and yakmomil mixed exosomes were treated. At this time, when 0.01% of Allantoin, a positive control, was treated, the expression rate was 50.66%.

시험예 10: 주름개선 효능 평가Test Example 10: Wrinkle improvement efficacy evaluation

황금, 약모밀 유래 엑소좀의 주름개선 효능을 확인하기 위해 추출물과 비교하여 COL1A1 발현에 미치는 영향을 확인하였다. 사람의 섬유아세포 세포주(human dermal fibroblast, HDFa)를 접종 후 100 IU/mL penicillin, 100 μg/mL streptomycin을 첨가한 Fibroblast Basal Medium(Medium 106) 배양 배지에서 37℃로 24시간동안 5% CO2 하에 배양하였다. 배양 후 배지를 버리고 황금 엑소좀, 약모밀 엑소좀 및 그 혼합 엑소좀, 황금 추출물, 약모밀 추출물을 각각 처리하고 48시간 배양하였다. 배양 후에 TransZol reagent를 이용하여 RNA를 추출한 뒤 RT-PCR(실시간 유전자 중합효소 연쇄반응)을 진행하여 피부 연결 조직을 유지시키는 collagen의 mRNA 변화량을 측정하였다. PCR에 의하여 생성된 산물은 1% agarose gel에서 전기영동하여 Gel Documentation system으로 확인하였다. 이때 음성 대조군으로는 PBS를 처리하였으며 양성 대조군으로는 Retinyl palmitate 50μM을 처리하였다. In order to confirm the anti-wrinkle efficacy of exosomes derived from gold and yakmomil, the effect on COL1A1 expression was confirmed compared with the extract. After inoculation of human dermal fibroblast (HDFa), 100 IU/mL penicillin and 100 μg/mL streptomycin were added in Fibroblast Basal Medium (Medium 106) culture medium at 37°C under 5% CO 2 for 24 hours. cultured. After culturing, the medium was discarded and treated with golden exosomes, yakmomil exosomes and their mixed exosomes, golden extracts, and yakmomil extracts, respectively, and cultured for 48 hours. After culturing, RNA was extracted using TransZol reagent, and then RT-PCR (real-time gene polymerase chain reaction) was performed to measure the amount of change in mRNA of collagen that maintains the skin connective tissue. The product generated by PCR was electrophoresed on 1% agarose gel and confirmed with the Gel Documentation system. At this time, PBS was treated as a negative control and 50 μM of Retinyl palmitate was treated as a positive control.

도 7은 상기 실시예 1, 2에 따라서 정제된 황금, 약모밀 유래 엑소좀과 그 혼합 엑소좀의 주름개선 효능을 COL1A1 발현으로 평가한 결과를 나타낸 그래프이다. 시험 결과, 황금 유래 엑소좀과 약모밀 유래 엑소좀을 처리하였을 때 농도 의존적으로 COL1A1의 발현이 증가하였으며 황금 추출물과 약모밀 추출물을 처리하였을 때보다 더 높은 주름개선 효과가 있음을 확인하였다. 황금과 약모밀 혼합 엑소좀을 처리하였을 때도 주름개선 효과가 우수함을 확인하였다. 이때 양성 대조군인 Retinyl palmitate 50Μm을 처리하였을 때는 161.33% 발현율을 보였다.7 is a graph showing the results of evaluating the wrinkle-improving efficacy of the exosomes derived from gold and yakmomil purified according to Examples 1 and 2 and the mixed exosomes by COL1A1 expression. As a result of the test, it was confirmed that the expression of COL1A1 was increased in a concentration-dependent manner when the gold-derived exosomes and the medicinal wheat-derived exosomes were treated, and there was a higher wrinkle improvement effect than when the golden extracts and the medicinal woolly extracts were treated. It was confirmed that the wrinkle improvement effect was excellent even when the golden and yakmomil mixed exosomes were treated. In this case, when the positive control group, Retinyl palmitate 50M, was treated, the expression rate was 161.33%.

제형예 1~3: 크림의 제조Formulation Examples 1-3: Preparation of cream

하기 표 5의 조성으로 상기 실시예에 따라서 정제된 황금 엑소좀, 약모밀 엑소좀을 포함하는 크림을 통상의 방법으로 제조하였다. 비교예 1의 황금 추출물을 함유하는 크림을 비교 제형예 1로 하고 비교예 2의 약모밀 추출물을 함유하는 크림을 비교 제형예 2로 하였다.With the composition shown in Table 5 below, a cream containing golden exosomes and yakmomil exosomes purified according to the above example was prepared by a conventional method. The cream containing the golden extract of Comparative Example 1 was used as Comparative Formulation Example 1, and the cream containing the Yakmomil extract of Comparative Example 2 was used as Comparative Formulation Example 2.

성분ingredient 제형예 1Formulation Example 1 제형예 2Formulation Example 2 제형예 3Formulation Example 3 비교
제형예 1
comparison
Formulation Example 1
비교
제형예 2
comparison
Formulation Example 2
함량(중량 %)Content (wt %) 황금 엑소좀(실시예 1)Golden exosomes (Example 1) 55 -- -- -- -- 약모밀 엑소좀(실시예 2)Yakmomil exosome (Example 2) -- 55 -- -- -- 황금 + 약모밀 엑소좀(실시예 3)Golden + Mildew wheat exosome (Example 3) -- -- 55 -- -- 황금 추출물(비교예 1)Golden Extract (Comparative Example 1) -- -- -- 55 -- 약모밀 추출물(비교예 2)Yak buckwheat extract (Comparative Example 2) -- -- -- -- 55 글리세린glycerin 1010 1010 1010 1010 1010 부틸렌글라이콜Butylene Glycol 55 55 55 55 55 글리세릴올리에이트glyceryl oleate 1.81.8 1.81.8 1.81.8 1.81.8 1.81.8 세테아릴올리베이트cetearyl olivate 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 솔비탄올리베이트Sorbitan Oliveate 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 카프릴릭/카프릭트리글리세라이드Caprylic/Capric Triglycerides 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 세틸에틸헥사노에이트Cetylethylhexanoate 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 비즈왁스beeswax 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 스쿠알란squalane 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 1,2-헥산다이올1,2-Hexanediol 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 콜레스테릴/베헤닐/옥틸도데실라우로일글루타메이트Cholesteryl/Behenyl/Octyldodecyllauroylglutamate 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 디메치콘dimethicone 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 사이클로펜타실록산/사이클로헥사실록산Cyclopentasiloxane/Cyclohexasiloxane 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 세티아릴알코올cetiaryl alcohol 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 미네랄 오일mineral oil 2.52.5 2.52.5 2.52.5 2.52.5 2.52.5 디소듐이디티에이Disodium EDIT 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 비에이치티BHT 0.050.05 0.050.05 0.050.05 0.050.05 0.050.05 토코페릴아세테이트tocopheryl acetate 0.30.3 0.30.3 0.30.3 0.30.3 0.30.3 판테놀panthenol 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 에칠헥실메톡시신나메이트Ethylhexylmethoxycinnamate 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 incense 0.010.01 0.010.01 0.010.01 0.010.01 0.010.01 정제수Purified water 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount

시험예 11: 황금, 약모밀 유래 엑소좀의 주름개선 평가Test Example 11: Wrinkle improvement evaluation of exosomes derived from gold and ryegrass wheat

황금 엑소좀(실시예 1), 약모밀 엑소좀(실시예 2) 및 그 혼합 엑소좀(실시예 3)의 주름 개선 효능을 확인하기 위해 30 ~ 50대의 성인 여성 20명을 대상으로 상기 제형예에서 제조된 크림을 얼굴 양쪽면에 바르고, LED 광원장치로 633nm의 적색광을 6주간 누적 시간 24시간 조사한 후, 주름 개선 효과를 실제 사용 테스트를 통하여 평가하였다.In order to confirm the anti-wrinkle effect of golden exosome (Example 1), yakmomil exosome (Example 2), and its mixed exosome (Example 3), 20 adult women in their 30s to 50s in the formulation example The prepared cream was applied to both sides of the face, and red light of 633 nm was irradiated with an LED light source for a cumulative time of 6 weeks for 24 hours, and then the wrinkle improvement effect was evaluated through an actual use test.

표 6은 상기 실시예에 따라서 정제된 황금, 약모밀 유래 엑소좀의 주름개선 효과를 실제 사용 테스트를 통하여 평가한 결과를 나타낸 표이다.Table 6 is a table showing the results of evaluating the wrinkle-improving effect of the exosomes derived from gold and yakmomil purified according to the above example through an actual use test.

주름개선효과Wrinkle improvement effect 우수Great 약간slightly 없음doesn't exist 제형예 1Formulation Example 1 1212 33 55 제형예 2Formulation Example 2 1212 77 1One 제형예 3Formulation Example 3 1414 44 22 비교제형예1Comparative Formulation Example 1 33 33 1414 비교제형예2Comparative Formulation Example 2 44 55 1111

상기 표 6의 결과에서도 알 수 있듯이, 본 발명의 황금 엑소좀, 약모밀 엑소좀과 황금, 약모밀 혼합 엑소좀이 포함된 크림에서 우수한 피부 주름개선 효과를 나타내었다.As can be seen from the results of Table 6, the cream containing the golden exosomes of the present invention, the yakmomil exosomes and the golden, yakmomil mixed exosomes exhibited an excellent skin wrinkle improvement effect.

시험예 12: 모발 성장 촉진 효과 시험Test Example 12: Hair growth promoting effect test

황금, 약모밀 유래 엑소좀의 모발 성장 촉진 효능을 확인하기 위해 농도 별 황금, 약모밀 추출물과 비교하여 모유두세포 증식에 미치는 영향을 확인하였다. 모낭을 구성하는 모유두세포인 HGDPC 세포주(Human follicle dermal papilla cell)를 96 well plate에 1×104 cells/mL로 분주하여 배양한 후 황금 엑소좀, 약모밀 엑소좀, 그 혼합 엑소좀과 황금 추출물, 약모밀 추출물 및 DHT(5α-dihydrotestosterone)를 10μM이 되도록 처리하여 48시간 배양하였다. 배양 후 10x BrdU solution을 처리하여 6시간 배양한 뒤 solution을 제거하고 Anti-BrdU Antibody를 처리하여 상온에서 1시간 동안 반응시켰다. Secondary Antibody HRP Conjugate를 첨가하여 반응시킨 뒤 PBS 로 세척 후 substrate solution을 넣어 반응시키고 stop solution을 이용하여 반응을 종료시킨 뒤 450nm에서 흡광도를 측정하였다. In order to confirm the hair growth promoting effect of exosomes derived from gold and ryegrass, the effect on the proliferation of dermal papilla cells was confirmed by comparing with the extracts of gold and ryegrass by concentration. Human follicle dermal papilla cells (HGDPC), which are dermal papilla cells constituting hair follicles, were dispensed and cultured at 1×10 4 cells/mL in a 96 well plate, followed by golden exosomes, weak hairy wheat exosomes, mixed exosomes and golden extracts; Yakmomil extract and DHT (5α-dihydrotestosterone) were treated to 10 μM and cultured for 48 hours. After incubation, 10x BrdU solution was treated and incubated for 6 hours, the solution was removed, and Anti-BrdU antibody was treated and reacted for 1 hour at room temperature. Secondary Antibody HRP Conjugate was added and reacted, washed with PBS, reacted by adding a substrate solution, and the reaction was terminated using a stop solution, and absorbance was measured at 450 nm.

도 8은 각 시료의 모발 성장 촉진 효능을 모유두세포 증식 효과로 평가한 결과를 나타낸 그래프이다. 시험 결과, 황금, 약모밀 유래 엑소좀과 황금, 약모밀 추출물을 처리하였을 때 농도 의존적으로 세포 증식이 증가하였으며 추출물에 비해 황금, 약모밀 유래 엑소좀을 처리하였을 때 증식이 더 증가됨을 확인하였다. 역시 황금과 약모밀 혼합 엑소좀을 처리하였을 때 가장 높은 세포 증식율을 보였으며 이 때 양성 대조군인 Minoxidil 10Μm을 처리하였을 때는 93.14% 증식율을 보였다.8 is a graph showing the results of evaluating the hair growth promoting effect of each sample as the dermal papilla cell proliferation effect. As a result of the test, it was confirmed that the cell proliferation was increased in a concentration-dependent manner when the gold- and yak-milk-derived exosomes and the golden-haired wheat extract were treated. Again, the highest cell proliferation rate was shown when treated with golden and yakmomil mixed exosomes, and at this time, when Minoxidil 10Mm, a positive control, was treated, the growth rate was 93.14%.

시험예 13: 5알파-환원효소(5α-reductase)저해 활성 시험Test Example 13: 5 alpha-reductase (5α-reductase) inhibitory activity test

황금, 약모밀 유래 엑소좀의 탈모방지 효능을 확인하기 위해 농도 별 황금, 약모밀 추출물과 비교하여 5알파-환원효소(5α-reductase)저해 활성에 미치는 영향을 확인하였다. 모낭을 구성하는 모유두세포인 HGDPC 세포주(Human follicle dermal papilla cell)를 24 well plate에 4×105 cells/mL로 분주하여 24시간 배양한 후 황금, 약모밀 엑소좀과 황금, 약모밀 추출물을 처리하여 1시간 배양하였다. 배양 후 테스토스테론(testosterone)을 처리하였으며 상등액을 분리하여 세포 펠렛을 수득하였다. 수득한 펠렛은 효소면역측정법을 이용하여 디하이드로테스토스테론 (DHT, dihydrotestosterone)의 농도를 측정하였다. DHT ElISA Kit strip-well에 세포 펠렛을 100μl씩 분주하고 DHT 항혈청을 25μl씩 분주하여 4℃에서 약 18시간동안 반응시켰다. 반응 후 각 웰에 HRP-Streptavidin Conjugate를 100μl씩 분주하고 30분간 상온에서 반응시킨 후 세척하였다. 세척 후 TMB 기질을 90μl을 분주하고 20분 이내로 상온에서 반응시킨 후 50μl의 stop 용액을 처리하고 처리 직후 450nm에서 흡광도를 측정하여 DHT의 농도를 정량하였다. In order to confirm the anti-hair loss efficacy of exosomes derived from gold and buckwheat, the effect on the 5 alpha-reductase inhibitory activity was confirmed by comparing the extracts of gold and yak buckwheat for each concentration. Human follicle dermal papilla cells (HGDPC), which are dermal papilla cells constituting hair follicles, were dispensed in a 24 well plate at 4×10 5 cells/mL and cultured for 24 hours. time incubation. After incubation, testosterone was treated, and the supernatant was separated to obtain a cell pellet. The obtained pellet was measured for the concentration of dihydrotestosterone (DHT, dihydrotestosterone) using an enzyme immunoassay. 100 μl of cell pellet was dispensed in each DHT ElISA Kit strip-well, and 25 μl of DHT antiserum was dispensed and reacted at 4° C. for about 18 hours. After the reaction, 100 μl of HRP-Streptavidin Conjugate was dispensed into each well, reacted at room temperature for 30 minutes, and then washed. After washing, 90 μl of TMB substrate was dispensed and reacted at room temperature within 20 minutes, treated with 50 μl of stop solution, and absorbance was measured at 450 nm immediately after treatment to quantify the concentration of DHT.

도 9는 각 시료의 탈모방지 효능을 5알파-환원효소(5α-reductase)저해 활성 시험으로 평가한 결과를 나타낸 그래프이다. 시료를 처리하지 않은 음성 대조군을 기준으로 5알파-환원효소 억제율로 계산하였다. 시험 결과, 황금, 약모밀 유래 엑소좀을 처리하였을 때 농도 의존적으로 저해 활성이 증가하였다. 황금과 약모밀 혼합 엑소좀을 처리하였을 때 가장 우수한 저해 활성을 나타냈다.9 is a graph showing the results of evaluating the hair loss prevention efficacy of each sample by a 5-alpha-reductase (5α-reductase) inhibitory activity test. The inhibition rate of 5 alpha-reductase was calculated based on the negative control group that was not treated with the sample. As a result of the test, the inhibitory activity was increased in a concentration-dependent manner when the exosomes derived from gold and yakmomil were treated. The best inhibitory activity was exhibited when treated with golden and yakmomil mixed exosomes.

시험예 14: 탈모방지 효과 시험Test Example 14: Hair Loss Prevention Effect Test

황금 엑소좀(실시예 1), 약모밀 엑소좀(실시예 2), 혼합 엑소좀(실시예 3)의 탈모 방지 효능을 확인하기 위해 농도 별 황금 추출물, 약모밀 추출물과 비교하여 초기 탈모가 진행되는 성인 30명을 대상으로 12주동안 실험을 진행하였다. 상기 실시예에 따라 정제된 황금 유래 엑소좀, 약모밀 유래 엑소좀과 그 혼합 엑소좀을 5% 농도로 처방하여 1일 1회 도포하고 약 20분 후 머리를 감게 하였다. 12주 후 탈락모를 수거하여 개수를 세었으며 그 결과를 아래 표 7에 나타내었다. 음성 대조군으로는 아무 것도 처리하지 않은 상태에서 탈락모를 수거하여 비교하였다.In order to confirm the hair loss prevention efficacy of the golden exosomes (Example 1), the weak wheat exosomes (Example 2), and the mixed exosomes (Example 3), adults with initial hair loss in comparison with the golden extracts and yakmomil extracts by concentration The experiment was conducted on 30 subjects for 12 weeks. Gold-derived exosomes purified according to the above example, yakmomil-derived exosomes and their mixed exosomes were prescribed at a concentration of 5%, applied once a day, and the hair was washed after about 20 minutes. After 12 weeks, the deciduous hairs were collected and counted, and the results are shown in Table 7 below. As a negative control, deciduous hairs were collected and compared in an untreated state.

처리농도(%)Treatment concentration (%) 탈락모 평균 개수(개)Average number of deciduous hairs (pieces) 음성 대조군negative control -- 7777 황금 엑소좀(실시예 1)Golden exosomes (Example 1) 55 5151 약모밀 엑소좀(실시예 2)Yakmomil exosome (Example 2) 55 5454 황금 + 약모밀 엑소좀(실시예 3)Golden + Mildew wheat exosome (Example 3) 55 5555 황금 추출물(비교예 1)Golden Extract (Comparative Example 1) 55 7373 약모밀 추출물(비교예 2)Yakmomil extract (Comparative Example 2) 55 7272

실험 결과, 황금 추출물, 약모밀 추출물에 비해 엑소좀을 처리하였을 때 탈락모의 개수가 현저히 감소하는 것을 확인하였다.As a result of the experiment, it was confirmed that the number of deciduous hairs was significantly reduced when the exosomes were treated compared to the golden extract and yakmomil extract.

제형예 4: 헤어토닉의 제조Formulation Example 4: Preparation of hair tonic

하기 표 8에 기재된 조성으로 헤어토닉을 통상의 방법에 따라 제조하였다.Hair tonic was prepared according to a conventional method with the composition shown in Table 8 below.

번호number 원료Raw material 함량 (중량 %)content (% by weight) 1One 피마자유castor oil 5.005.00 22 황금 엑소좀(실시예 1)Golden exosomes (Example 1) 3.003.00 33 약모밀 엑소좀(실시예 2)Yakmomil exosome (Example 2) 3.003.00 44 판테놀panthenol 0.200.20 55 레조시놀resorcinol 0.100.10 66 살리실산salicylic acid 0.100.10 77 토코페릴아세테이트tocopheryl acetate 0.100.10 88 피리독신에이치씨엘Pyridoxine HCL 0.100.10 99 멘톨menthol 0.050.05 1010 색소pigment 적량appropriate amount 1111 조합향료combination spice 적량appropriate amount 1212 에탄올ethanol 적량appropriate amount 1313 정제수Purified water To 100To 100

제형예 5: 헤어 샴푸의 제조Formulation Example 5: Preparation of hair shampoo

하기 표 9에 기재된 조성으로 헤어 샴푸를 통상의 방법에 따라 제조하였다.A hair shampoo was prepared according to a conventional method with the composition shown in Table 9 below.

번호number 원료Raw material 함량 (중량 %)content (% by weight) 1One 암모늄라우릴설페이트Ammonium Lauryl Sulfate 20.0020.00 22 암모늄라우레스설페이트Ammonium Laureth Sulfate 20.0020.00 33 코카마이드프로필베타인cocamide propyl betaine 6.006.00 44 황금 엑소좀(실시예 1)Golden exosomes (Example 1) 3.003.00 55 약모밀 엑소좀(실시예 2)Yakmomil exosome (Example 2) 3.003.00 66 디메치콘(50%)Dimethicone (50%) 2.002.00 77 디메치콘(70%)Dimethicone (70%) 2.002.00 88 디소듐이디티에이Disodium EDIT 0.030.03 99 메칠클로로이소치아졸리논 메칠이소치아졸리논 혼합액Methylchloroisothiazolinone Methylisothiazolinone Mixture 0.030.03 1010 코카마이드미파cocamide mipa 적량appropriate amount 1111 카보머Carbomer 적량appropriate amount 1212 에탄올ethanol 적량appropriate amount 1313 DL-판테놀DL-Panthenol 적량appropriate amount 1414 토코페릴아세테이트tocopheryl acetate 적량appropriate amount 1515 트리에탄올아민triethanolamine 적량appropriate amount 1616 조합향료combination spice 적량appropriate amount 1717 멘톨menthol 적량appropriate amount 1818 정제수Purified water To 100To 100

제형예 6: 헤어 컨디셔너의 제조Formulation Example 6: Preparation of hair conditioner

하기 표 10에 기재된 조성으로 헤어 컨디셔너를 통상의 방법에 따라 제조하였다.A hair conditioner was prepared according to a conventional method with the composition shown in Table 10 below.

번호number 원료Raw material 함량 (중량 %)content (% by weight) 1One 염화스테아릴메틸벤질 암모늄(25%)Stearylmethylbenzyl ammonium chloride (25%) 5.005.00 22 세탄올cetanol 3.503.50 33 황금 엑소좀(실시예 1)Golden exosomes (Example 1) 3.003.00 44 약모밀 엑소좀(실시예 2)Yakmomil exosome (Example 2) 3.003.00 55 프로필렌글라이콜propylene glycol 2.502.50 66 자기유화형 모노스테아린산글리세린Self-emulsifying glycerin monostearate 1.501.50 77 파라옥시안식향산메틸methyl paraoxybenzoate 0.300.30 88 색소pigment 적량appropriate amount 99 조합향료combination spice 적량appropriate amount 1010 정제수Purified water To 100To 100

Claims (8)

황금 엑소좀, 약모밀 엑소좀 또는 그 혼합 엑소좀을 유효성분으로 함유하는 화장료 조성물에 있어서,
상기 유효성분으로서의 황금 엑소좀과 약모밀 엑소좀은,
(A)황금 또는 약모밀을 40~60℃, 20~24시간 열풍건조 처리하는 단계;
(B)열풍건조 처리한 황금 또는 약모밀을 30~40℃의 물에 침지하는 단계;
(C)침지시킨 황금 또는 약모밀을 착즙하는 단계;
(D)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계;
(E)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계;
(F)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및
(G)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 방법에 의하여 정제된 것임을 특징으로 하는 화장료 조성물.
In a cosmetic composition containing golden exosome, yakmomil exosome or a mixed exosome thereof as an active ingredient,
Golden exosomes and yakmomil exosomes as the active ingredients are,
(A) hot-air drying treatment of golden or weak wheat at 40 to 60° C. for 20 to 24 hours;
(B) immersing the hot air-dried golden or weak wheat in water at 30-40 ℃;
(C) squeezing the immersed gold or yakmomil;
(D) centrifuging the juice at 1,000xg to 10,000xg to obtain a supernatant;
(E) freeze-drying the supernatant in which exosomes are present;
(F) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; and
(G) A cosmetic composition, characterized in that it is purified by a method comprising the step of obtaining a lower layer solution in which the exosomes are concentrated in the aqueous two-phase system.
삭제delete 제1항에 있어서, 상기 (A) 단계에서의 열풍건조 처리는 50℃의 온도에서 24시간 동안 수행하는 것임을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the hot air drying treatment in step (A) is performed at a temperature of 50° C. for 24 hours. 제1항에 있어서, 황금 엑소좀, 약모밀 엑소좀 또는 그 혼합 엑소좀은 조성물 전체중량에 대하여 0.0001~30.0%(w/w) 함유되는 것임을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the golden exosome, yakmomil exosome or a mixture thereof is contained in an amount of 0.0001 to 30.0% (w/w) based on the total weight of the composition. 제1항에 있어서, 상기 화장료 조성물은 항산화용, 항염용 또는 주름개선용임을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the cosmetic composition is for antioxidant, anti-inflammatory, or wrinkle improvement. 제1항에 있어서, 상기 화장료 조성물은 모발 성장 촉진용 또는 탈모 방지용임을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the cosmetic composition is for promoting hair growth or preventing hair loss. (A)황금 또는 약모밀을 40~60℃, 20~24시간 열풍건조 처리하는 단계;
(B)열풍건조 처리한 황금 또는 약모밀을 30~40℃의 물에 침지하는 단계;
(C)침지시킨 황금 또는 약모밀을 착즙하는 단계;
(D)상기 착즙액을 1,000xg~10,000xg에서 원심분리하여 상층액을 수득하는 단계;
(E)엑소좀이 존재하는 상기 상층액을 동결건조하는 단계;
(F)상기 동결건조물에 PEG(Polyethylene glycol)/Dextran을 사용하여 수성 2상계를 형성하는 단계; 및
(G)상기 수성 2상계 중 엑소좀이 농축된 하층액을 수득하는 단계를 포함하는 황금 또는 약모밀 엑소좀의 정제방법.
(A) hot-air drying treatment of golden or weak wheat at 40 to 60° C. for 20 to 24 hours;
(B) immersing the hot air-dried golden or weak wheat in water at 30-40 ℃;
(C) squeezing the immersed gold or yakmomil;
(D) centrifuging the juice at 1,000xg to 10,000xg to obtain a supernatant;
(E) freeze-drying the supernatant in which exosomes are present;
(F) forming an aqueous two-phase system using PEG (Polyethylene glycol)/Dextran in the lyophilisate; and
(G) A method of purifying golden or weak wheat exosomes comprising the step of obtaining a lower layer in which the exosomes are concentrated in the aqueous two-phase system.
제7항에 있어서, 상기 (A) 단계에서의 열풍건조 처리는 50℃의 온도에서 24시간 동안 수행하는 것임을 특징으로 하는 황금 또는 약모밀 엑소좀의 정제방법.The method of claim 7, wherein the hot air drying treatment in step (A) is performed at a temperature of 50° C. for 24 hours.
KR1020210170925A 2021-12-02 2021-12-02 Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome KR102391636B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210170925A KR102391636B1 (en) 2021-12-02 2021-12-02 Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210170925A KR102391636B1 (en) 2021-12-02 2021-12-02 Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome

Publications (1)

Publication Number Publication Date
KR102391636B1 true KR102391636B1 (en) 2022-04-28

Family

ID=81446775

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210170925A KR102391636B1 (en) 2021-12-02 2021-12-02 Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome

Country Status (1)

Country Link
KR (1) KR102391636B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102413205B1 (en) * 2022-04-11 2022-06-24 주식회사 에이바이오머티리얼즈 Cosmetic composition for skin moisturizing, soothing, anti-inflammation, skin cell regeneration and anti-wrinkle containing Perilla Frutescens exosome, Eucalyptus Globulus exosome
CN115634254A (en) * 2022-10-10 2023-01-24 重庆生物智能制造研究院 Preparation method and application of allium chinense plant exosome
KR102502664B1 (en) * 2022-09-23 2023-02-23 주식회사 에이바이오머티리얼즈 Cosmetic composition for improving skin and hair condition containing Solanum Lycopersicum(Tomato) Fruit exosome, Brassica Oleracea Italica(Broccoli) exosome
KR102564765B1 (en) * 2022-10-25 2023-08-09 (주)지에프씨생명과학 Cosmetic compositions for anti-inflammatory and skin soothing comprising exosome derived from lavandula angustifolia, houttuynia cordata or melaleuca alternifolia as an active ingredient

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102125567B1 (en) 2019-07-02 2020-06-22 한양대학교 에리카산학협력단 Large-Scale Production of Plant Derived Exosomes
KR20210018735A (en) 2019-08-09 2021-02-18 주식회사 피에프네이처 Compositions for Anti-Acne and Anti-Inflammatory Effect Comprising Complex Extract of Houttuynia cordata
KR102265811B1 (en) 2021-04-09 2021-06-16 주식회사 에이바이오머티리얼즈 Method for isolation and purification of Centella asiatica exosome and cosmetic composition containing the same
KR20210141261A (en) * 2020-05-15 2021-11-23 주식회사 엑소스템텍 Antioxidant cosmetic composition and functional cosmetics comprising the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102125567B1 (en) 2019-07-02 2020-06-22 한양대학교 에리카산학협력단 Large-Scale Production of Plant Derived Exosomes
KR20210018735A (en) 2019-08-09 2021-02-18 주식회사 피에프네이처 Compositions for Anti-Acne and Anti-Inflammatory Effect Comprising Complex Extract of Houttuynia cordata
KR20210141261A (en) * 2020-05-15 2021-11-23 주식회사 엑소스템텍 Antioxidant cosmetic composition and functional cosmetics comprising the same
KR102265811B1 (en) 2021-04-09 2021-06-16 주식회사 에이바이오머티리얼즈 Method for isolation and purification of Centella asiatica exosome and cosmetic composition containing the same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102413205B1 (en) * 2022-04-11 2022-06-24 주식회사 에이바이오머티리얼즈 Cosmetic composition for skin moisturizing, soothing, anti-inflammation, skin cell regeneration and anti-wrinkle containing Perilla Frutescens exosome, Eucalyptus Globulus exosome
KR102502664B1 (en) * 2022-09-23 2023-02-23 주식회사 에이바이오머티리얼즈 Cosmetic composition for improving skin and hair condition containing Solanum Lycopersicum(Tomato) Fruit exosome, Brassica Oleracea Italica(Broccoli) exosome
CN115634254A (en) * 2022-10-10 2023-01-24 重庆生物智能制造研究院 Preparation method and application of allium chinense plant exosome
CN115634254B (en) * 2022-10-10 2024-04-30 重庆生物智能制造研究院 Preparation method and application of allium chinense plant exosome
KR102564765B1 (en) * 2022-10-25 2023-08-09 (주)지에프씨생명과학 Cosmetic compositions for anti-inflammatory and skin soothing comprising exosome derived from lavandula angustifolia, houttuynia cordata or melaleuca alternifolia as an active ingredient

Similar Documents

Publication Publication Date Title
KR102391636B1 (en) Cosmetic composition for improving skin and hair condition containing Scutellaria baicalensis exosome, Houttuynia cordata exosome
KR102348510B1 (en) Cosmetic composition containing Iris root exosome
KR102329247B1 (en) Method for isolation and purification of Portulaca oleracea exosome and cosmetic composition containing the same
KR101132246B1 (en) The hair growth solution mainly comprised of ginsenoside rg3 and rh2, and the hair treatment composition
KR102413205B1 (en) Cosmetic composition for skin moisturizing, soothing, anti-inflammation, skin cell regeneration and anti-wrinkle containing Perilla Frutescens exosome, Eucalyptus Globulus exosome
KR20170019829A (en) A Cosmetic Composition Having An Antioxidation, Anti-Inflamation Effects Contaning Rosemarimus Officinalis, Chrysanthemum Indicum Flower , Magnolia Kobus Flower , Polygonum Cuspidatum Root Extracts
KR102413200B1 (en) Cosmetic composition containing Rosemary exosome, Lotus leaf exosome
US20240024224A1 (en) Anti-aging and antioxidant cosmetic composition containing broccoli exosomes as active ingredient and functional cosmetics comprising same
KR102300581B1 (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
KR102214985B1 (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
KR20150078868A (en) Cosmetic composition containing ginsenoside Rd, Rb2 and Bambusae Caulis in Taeniam extracts
KR102432749B1 (en) Cosmetic composition containing Pteridium aquilinum exosome
KR102257448B1 (en) Cosmetic composition containing black kelp
KR102450862B1 (en) Cosmetic composition containing Cnidium officinale exosome, Paeonia lactiflora exosome
KR102502664B1 (en) Cosmetic composition for improving skin and hair condition containing Solanum Lycopersicum(Tomato) Fruit exosome, Brassica Oleracea Italica(Broccoli) exosome
KR102534797B1 (en) Preparation method of nanoparticles containing anemarrhena asphodeloides extract, polydeoxyribonucleotide and physiologically active materials and cosmetic composition comprising the same
KR20210091430A (en) Cosmetic composition containing natural complex extracts as active ingredient
JP2010024211A (en) Cell proliferation promoting agent
KR102523528B1 (en) Cosmetic composition containing grapefruit exosome and camellia japonica flower exosome
KR20170137436A (en) Composition for improving skin condition comprising herb extracts mixture
KR102523523B1 (en) Cosmetic composition for improving skin and hair condition containing Nepeta Cataria exosome and Spinacia Oleracea exosome
KR102391645B1 (en) Cosmetic composition for hair containing fig exosome
KR102485314B1 (en) Cosmetic composition comprising fermented shea butter and exosome derived from lactic acid bacteria
KR102635022B1 (en) Cosmetic composition containing Perilla Ocymoides exosome, Eucalyptus Globulus exosome, elastic liposome containing azulene and peptides
KR102613510B1 (en) Preparation method of nanoparticles containing peptide and physiologically active materials and cosmetic composition comprising the same

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant